Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan

BACKGROUND: Drug-resistant TB (DR-TB) remains a major public health threat. In 2022, Uzbekistan reported 2,117 cases of DR-TB, with 69% tested for fluoroquinolone resistance. Limited information is available on the prevalence of resistance to bedaquiline, linezolid, and fluoroquinolone, which are ke...

Descripció completa

Dades bibliogràfiques

Autors principals:	S. Moe, I. Azamat, S. Allamuratova, M. Oluya, A. Khristusev, M.L. Rekart, K. Mamitova, G. Bidwell, C. Gomez-Restrepo, B. Kalmuratov, Z. Tigay, N. Parpieva, K. Safaev, N. Sitali, D. Gomez, A. Mikhail, A. Sinha
Format:	Artigo
Idioma:	Inglês
Publicat:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-09-01
Col·lecció:	IJTLD Open
Matèries:	epidemiology second-line drug-resistant tb group-a drug-resistant tb risk factors
Accés en línia:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000009/art00003
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!